Cognition, Cytokines, Blood–Brain Barrier, and Beyond in COVID-19: A Narrative Review
International Journal of Molecular Sciences · 05.01.2026 · 27 (1) · 546
DOI: 10.3390/ijms27010546 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 05.01.2026. Verfasst von Ana Barajas und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Health Psychology, Universitat Autònoma de Barcelona, Bellatera, 08193 Cerdanyola del Vallès, Spain. Hauptthemen laut MEDLINE: Blood-Brain Barrier, COVID-19, Cytokines, Cognition. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III.
Abstract (Originalsprache)
Numerous studies report cognitive impairment in COVID-19 patients from the acute to post-acute phases, linked to blood inflammation affecting blood–brain barrier (BBB) permeability and causing leakage of glial and neuronal proteins. However, a clear classification of these cognitive deficits and molecular blood events over time is still lacking. This narrative review summarizes the neuropsychological consequences of COVID-19 and evidence of altered cytokines and BBB disruption as potential mediators of cognitive impairment across post-infection phases. Post-COVID-19 cognitive dysfunction appears to follow a temporal course, evolving from acute focal deficits in attention, working memory, and executive function to more persistent multidomain impairments. We reviewed key cytokines released into the blood during COVID-19 infection, including antiviral (IFNγ, CXCL1, CXCL10), inflammatory (IL-1β, IL-2, IL-4, IL-6, IL-7, IL-8, IL-10, GM-CSF, TNFα), and monocyte chemoattractants (MCP1/CCL2, MCP3/CCL7, MIP-1α/CCL3, GM-CSF, G-CSF). This analysis shows that several inflammatory and viral cytokines remain elevated beyond the acute phase and are associated with cognitive deficits, including IL-6, IL-13, IL-8, IL-1β, TNFα, and MCP1 in long-term post-COVID-19 patients. In addition, we examined studies analyzing changes over time in neurovascular unit proteins as biomarkers of BBB disruption, including extracellular matrix proteins (PPIA, MMP-9), astrocytes (S100β, GFAP), and neurons (NFL). These proteins are elevated in acute COVID-19 but generally return to control levels within six months, suggesting BBB restoration. However, in patients followed for over a year, BBB disruption persists only in those with cognitive impairment and is associated with systemic inflammation, with TGFβ as a related biomarker. Although cognitive sequelae can persist for over 12 months after SARS-CoV-2 infection, further studies are needed to investigate long-term neurocognitive outcomes and their link to sustained proinflammatory cytokine elevation and brain impact.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical and Health Psychology, Universitat Autònoma de Barcelona, Bellatera, 08193 Cerdanyola del Vallès, Spain.
- Serra Húnter Programme, Government of Catalonia, 08002 Barcelona, Spain.
- Psiquiatria Molecular, Institut de Recerca Sant Joan de Déu, Parc Sanitari Sant Joan de Déu, 08830 Sant Boi de Llobregat, Spain.
- Departamento de Ciencias Biológicas y Químicas, Facultad De Ciencias, Universidad San Sebastián, Sede Tres Pascualas Lientur 1457, Concepción 4080871, Chile.
- Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM (Biomedical Network Research Center of Mental Health), Ministry of Economy, Industry and Competitiveness Institute of Health Carlos III, 28029 Madrid, S…
- Faculty of Medicine, University of Vic-Central University of Catalonia, 08500 Vic, Spain.
ORCID-Profile: Ana Barajas, América Vera-Montecinos
Förderung
- Instituto de Salud Carlos III
Zitieren
APA
Barajas, A., Riquelme-Alacid, G., Vera-Montecinos, A., & Ramos, B. (2026). Cognition, Cytokines, Blood–Brain Barrier, and Beyond in COVID-19: A Narrative Review. International Journal of Molecular Sciences, 27(1), 546. https://doi.org/10.3390/ijms27010546
Vancouver
Barajas A, Riquelme-Alacid G, Vera-Montecinos A, Ramos B. Cognition, Cytokines, Blood–Brain Barrier, and Beyond in COVID-19: A Narrative Review. International Journal of Molecular Sciences. 2026;27(1):546. doi:10.3390/ijms27010546
BibTeX
@article{Barajas2026,
author = {Barajas, Ana and Riquelme-Alacid, Gemma and Vera-Montecinos, América and Ramos, Belén},
title = {Cognition, Cytokines, Blood–Brain Barrier, and Beyond in COVID-19: A Narrative Review},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {1},
pages = {546},
doi = {10.3390/ijms27010546}
}
EUVIMED